Physician Communication That Combined Results Of Unrelated Studies Gets Rebuke From US FDA

 
• By Brenda Sandburg
  
Two studies
US FDA objects to Roszet drug promotion combining the results of two studies • Source: Shutterstock

More from Marketing & Advertising

More from Compliance